HOW DAYSPAN DECIDES · PUBLIC RECORD
Built through review,
not personality.
You do not need a founder story to decide whether a supplement company is serious. You need to see what it publishes, what it leaves open, and what it refuses to sell before it can verify the details.
THE WORK LEDGER
What began when, and what is public now.
Dates reflect company history or the public record—never invented progress milestones.
- 01Inspect →
2017 · Company history
The first Dayspan Sleep formula work began
The 2017 starting formula centered magnesium bisglycinate, passionflower, and lemon balm—not glycine. It was an earlier direction, not the current formula or clinical proof of it.
- 02Inspect →
September 2026 · Published
Glycine formula direction made public
Five active ingredients, their working amounts, study context, funding, and limitations are available to inspect. The finished combination has not been clinically tested.
- 03Inspect →
September 2026 · Published
Evidence and claims rules made public
Dayspan grades evidence, keeps funding and limitations attached, and does not turn ingredient research into a finished-product trial.
- 04Inspect →
September 2026 · Published
Ingredient choices explained within each product
Each product story explains what is in its formula and why particular ingredients are left out.
- 05Inspect →
Before sale · Required before sale
Final label, terms, and first-batch report
Checkout stays closed until the final label, directions, purchase terms, and third-party identity, potency, and contaminant report are public.
WHAT WE WILL NOT FAKE
No borrowed authority. No manufactured proof.
Dayspan has no customer reviews, completed batch reports, named medical endorsers, or founder story to use as a shortcut. Those signals appear only when they are real, relevant, and available for you to check.